Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Peter R, Hollett"'
Publikováno v:
Nephrology (Carlton, Vic.). 17
Bone disease is a major cause of morbidity post renal transplantation. The authors present a case of adynamic bone disease and atypical fractures associated with the use of bisphosphonates following renal transplantation. The uncertain role of parath
Publikováno v:
Nephrology (Carlton, Vic.). 16(8)
The Australian Pharmaceutical Benefits Scheme (PBS) commenced cost subsidization for haemodialysis patients of sevelamer in December 2007, cinacalcet in July 2008 and lanthanum in May 2009. To determine the impact of PBS listing of these medications,